{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:03:35Z","timestamp":1759230215857},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T00:00:00Z","timestamp":1372118400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0067256","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T21:07:09Z","timestamp":1372194429000},"page":"e67256","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Interleukin-21 Enhances Rituximab Activity in a Cynomolgus Monkey Model of B Cell Depletion and in Mouse B Cell Lymphoma Models"],"prefix":"10.1371","volume":"8","author":[{"given":"Cecile M.","family":"Krejsa","sequence":"first","affiliation":[]},{"given":"Rick D.","family":"Holly","sequence":"additional","affiliation":[]},{"given":"Mark","family":"Heipel","sequence":"additional","affiliation":[]},{"given":"Ken M.","family":"Bannink","sequence":"additional","affiliation":[]},{"given":"Rebecca","family":"Johnson","sequence":"additional","affiliation":[]},{"given":"Richard","family":"Roque","sequence":"additional","affiliation":[]},{"given":"Jane","family":"Heffernan","sequence":"additional","affiliation":[]},{"given":"Julie","family":"Hill","sequence":"additional","affiliation":[]},{"given":"Lay","family":"Chin","sequence":"additional","affiliation":[]},{"given":"Felecia","family":"Wagener","sequence":"additional","affiliation":[]},{"given":"Faith","family":"Shiota","sequence":"additional","affiliation":[]},{"given":"Katherine","family":"Henderson","sequence":"additional","affiliation":[]},{"given":"Pallavur V.","family":"Sivakumar","sequence":"additional","affiliation":[]},{"given":"Hong-Ping","family":"Ren","sequence":"additional","affiliation":[]},{"given":"Fariba","family":"Barahmand-pour","sequence":"additional","affiliation":[]},{"given":"Don","family":"Foster","sequence":"additional","affiliation":[]},{"given":"Chris","family":"Clegg","sequence":"additional","affiliation":[]},{"given":"Wayne","family":"Kindsvogel","sequence":"additional","affiliation":[]},{"given":"Rafael","family":"Ponce","sequence":"additional","affiliation":[]},{"given":"Steven D.","family":"Hughes","sequence":"additional","affiliation":[]},{"given":"Kim","family":"Waggie","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2013,6,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.167.1.1","article-title":"Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex","volume":"167","author":"H Asao","year":"2001","journal-title":"J Immunol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"8725","DOI":"10.1021\/bi0202023","article-title":"The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3","volume":"41","author":"T Habib","year":"2002","journal-title":"Biochemistry"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/35040504","article-title":"Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function","volume":"408","author":"J Parrish-Novak","year":"2000","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"7867","DOI":"10.4049\/jimmunol.175.12.7867","article-title":"IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells","volume":"175","author":"R Ettinger","year":"2005","journal-title":"J Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.4049\/jimmunol.173.1.657","article-title":"Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis","volume":"173","author":"H Jin","year":"2004","journal-title":"J Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.4049\/jimmunol.179.9.5886","article-title":"Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration","volume":"179","author":"S Kuchen","year":"2007","journal-title":"J Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1182\/blood-2005-09-3535","article-title":"Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells","volume":"107","author":"D de Totero","year":"2006","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1182\/blood-2009-08-239996","article-title":"Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas","volume":"115","author":"KA Sarosiek","year":"2010","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.4049\/jimmunol.172.4.2048","article-title":"IL-21 induces the functional maturation of murine NK cells","volume":"172","author":"J Brady","year":"2004","journal-title":"J Immunol"},{"key":"ref10","first-page":"9016","article-title":"In vivo antitumor activity of interleukin 21 mediated by natural killer cells","volume":"63","author":"G Wang","year":"2003","journal-title":"Cancer Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00262-007-0285-4","article-title":"Interleukin 21 therapy increases the density of tumor infiltrating CD8(+ ) T cells and inhibits the growth of syngeneic tumors","volume":"56","author":"H Sondergaard","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"ref12","first-page":"1295","article-title":"Expert Opinion on Biological Therapy","volume":"8","year":"2008"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1517\/14712598.2010.480971","article-title":"Interleukin-21: updated review of Phase I and II clinical trials in metastatic renal cell carcinoma, metastatic melanoma and relapsed\/refractory indolent non-Hodgkin\u2019s lymphoma","volume":"10","author":"MH Hashmi","year":"2010","journal-title":"Expert Opinion on Biological Therapy"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1182\/blood.V91.5.1644","article-title":"Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies","volume":"91","author":"D Shan","year":"1998","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1182\/blood-2002-02-0469","article-title":"In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas","volume":"101","author":"O Manches","year":"2003","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/annonc\/mdg175","article-title":"An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab","volume":"14","author":"J Boye","year":"2003","journal-title":"Ann Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev.med.55.091902.104249","article-title":"Rituximab: expanding role in therapy for lymphomas and autoimmune diseases","volume":"55","author":"W Rastetter","year":"2004","journal-title":"Annu Rev Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1158\/1078-0432.CCR-06-1571","article-title":"A phase 2 study of rituximab in combination with recombinant interleukin-2 for rituximab-refractory indolent non-Hodgkin&apos;s lymphoma","volume":"12","author":"KD Khan","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1158\/1078-0432.CCR-06-1245","article-title":"Randomized phase II study of interleukin-12 in combination with rituximab in previously treated non-Hodgkin\u2019s lymphoma patients","volume":"12","author":"SM Ansell","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1182\/blood.V86.1.183.bloodjournal861183","article-title":"Circulation of human hematopoietic cells in severe combined immunodeficient mice after Cl<sub>2<\/sub>MDP-liposome-mediated macrophage depletion","volume":"86","author":"CC Fraser","year":"1995","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/01.cji.0000211315.21116.07","article-title":"Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-Hodgkin lymphoma","volume":"30","author":"DE Lopes de Menezes","year":"2007","journal-title":"J Immunother"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S1567-5769(03)00147-4","article-title":"Differential in vivo effects of rituximab on two B-cell subsets in cynomolgus monkeys","volume":"3","author":"Y Vugmeyster","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","article-title":"Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20","volume":"83","author":"ME Reff","year":"1994","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/cyto.a.10030","article-title":"Effect of anti-CD20 monoclonal antibody, Rituxan, on cynomolgus monkey and human B cells in a whole blood matrix","volume":"52","author":"Y Vugmeyster","year":"2003","journal-title":"Cytometry A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/cyto.a.20039","article-title":"B-cell subsets in blood and lymphoid organs in Macaca fascicularis","volume":"61","author":"Y Vugmeyster","year":"2004","journal-title":"Cytometry A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4049\/jimmunol.154.1.180","article-title":"Multiple defects in innate and adaptive immunologic function in NOD\/LtSz-scid mice","volume":"154","author":"LD Shultz","year":"1995","journal-title":"J Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.leukres.2011.02.006","article-title":"Interleukin-21 and rituximab enhance NK cell functionality in patients with B-cell chronic lymphocytic leukaemia","volume":"35","author":"CW Eskelund","year":"2011","journal-title":"Leukemia Research"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/1091581812449661","article-title":"Preclinical safety, pharmacokinetics, and pharmacodynamics of recombinant human IL-21 in Cynomolgus macaques (Macaca fascicularis)","volume":"31","author":"KS Waggie","year":"2012","journal-title":"Intl J Toxicol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.4049\/jimmunol.174.7.4389","article-title":"The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice","volume":"174","author":"Y Hamaguchi","year":"2005","journal-title":"J Immunol"},{"key":"ref30","first-page":"5866","article-title":"Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin\u2019s lymphoma severe combined immunodeficiency mouse model","volume":"9","author":"FJ Hernandez-Ilizaliturri","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4049\/jimmunol.177.1.120","article-title":"Interleukin-21 enhances NK cell activation in response to antibody-coated targets","volume":"177","author":"JM Roda","year":"2006","journal-title":"J Immunol"},{"key":"ref32","first-page":"1185","article-title":"Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities. Blood","volume":"109","author":"JA McEarchern","year":"2007"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00281-006-0057-9","article-title":"Fcgamma receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity","volume":"28","author":"TF Tedder","year":"2006","journal-title":"Springer Semin Immunopathol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"7521","DOI":"10.4049\/jimmunol.173.12.7521","article-title":"In vivo and in vitro roles of IL-21 in inflammation","volume":"173","author":"M Pelletier","year":"2004","journal-title":"J Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1189\/jlb.0403164","article-title":"A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis","volume":"74","author":"DG Mordue","year":"2003","journal-title":"J Leukoc Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.4049\/jimmunol.178.4.2000","article-title":"Distinct differentiation potential of blood monocyte subsets in the lung","volume":"178","author":"L Landsman","year":"2007","journal-title":"J Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1084\/jem.20040119","article-title":"The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy","volume":"199","author":"J Uchida","year":"2004","journal-title":"J Exp Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1189\/jlb.0905503","article-title":"IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells","volume":"79","author":"M Strengell","year":"2006","journal-title":"J Leukoc Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1172\/JCI27727","article-title":"The IL-21 receptor augments Th2 effector function and alternative macrophage activation","volume":"116","author":"J Pesce","year":"2006","journal-title":"J Clin Invest"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/art.20218","article-title":"Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis","volume":"50","author":"A Jungel","year":"2004","journal-title":"Arthritis Rheum"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1158\/1078-0432.CCR-12-0456","article-title":"A Phase I dose-finding trial of recombinant interleukin-21 and rituximab in relapsed and refractory low grade B-cell lymphoproliferative disorders","volume":"18","author":"JM Timmerman","year":"2012","journal-title":"Clin Cancer Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0067256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T16:13:49Z","timestamp":1688314429000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0067256"}},"subtitle":[],"editor":[{"given":"Gunnar F.","family":"Kaufmann","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2013,6,25]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,6,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0067256","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,25]]}}}